Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00943241 · ClinicalTrials.gov registry record
Screening in Myocardial Perfusion Patients
A clinical trial of Breast Cancer, sponsored by Mayo Clinic.
- Completed
- Registry status
- 322
- Enrollment target
- 1
- Study location
NCT00943241: Completed study of Breast Cancer, sponsored by Mayo Clinic.
NCT00943241 is a study of Breast Cancer that has completed, run by Mayo Clinic. The registered enrollment target is 322 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00943241, a study of Breast Cancer, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 322 participants
- Enrollment target
- 1
- Study location
Study Summary
To expand the understanding of the uptake and distribution of Tc-99m sestamibi in the breast in a normal female population undergoing myocardial perfusion imaging using Molecular Breast Imaging (MBI).
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00943241
The ClinicalTrials.gov registry entry for NCT00943241 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00943241 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00943241 about?
NCT00943241 is a clinical study titled "Screening in Myocardial Perfusion Patients". To expand the understanding of the uptake and distribution of Tc-99m sestamibi in the breast in a normal female population undergoing myocardial perfusion imaging using Molecular Breast Imaging (MBI).
What is the current status of trial NCT00943241?
This trial is currently completed. The enrollment target is 322 participants. The study started on 2008-07. Estimated completion is 2010-06.
What conditions does trial NCT00943241 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT00943241?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00943241 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.